Microcrystalline cellulose (MCC) has been one of the most widely used excipients in pharmaceutical industry for many decades. With its versatile functional properties, MCC is increasingly becoming an important part of various drug delivery systems. This article will provide an overview of MCC covering its production, properties and applications in pharmaceutical formulations.

What is MCC?

Microcrystalline cellulose is a partially depolymerized cellulose prepared by treating alpha-cellulose obtained from pulping wood or cotton fibers. It is composed of crystalline cellulose molecules in the form of porous particles aggregated together in a loose structure. The microcrystallites impart mechanical strength and moisture retention capability to MCC making it very useful as a binder and filler in tablets and capsule formulations.

Production of MCC

The production of Microcrystalline Cellulose starts with careful selection and purification of raw cellulose fibers. Alpha-cellulose rich woods like softwood are commonly used. The cellulose is treated with mineral acids like hydrochloric acid or sulfuric acid which causes a controlled breakdown of beta-1,4 glycosidic bonds between glucose units of the polymer chain. This depolymerization leads to release of individual microcrystallites loosely bonded together. The material is then filtered, washed and dried to obtain purified MCC particles. Modern production methods employ optimized reaction conditions like higher acid concentration, longer reaction time and controlled temperature to obtain MCC with desired qualities.

Properties and Characterization of MCC

MCC particles are porous ranging in size from 1-300 μm with a mean particle diameter of 50-200 μm. The microporous structure gives MCC a very large surface area of 1-15 m2/g which helps in moisture absorption. It has low density of 0.45 g/cc and residual moisture content below 4%.

MCC shows reduced crystallinity compared native cellulose due to partial depolymerization. X-ray diffraction studies reveal crystalline peaks between 10-35° 2θ. The degree of crystallinity usually ranges between 30-60%. Thermal gravimetric analysis exhibits good thermal stability up to 230°C. Based on micromeritic properties like bulk density, tapped density, compressibility index and Hausner's ratio, different grades of MCC are classified as directly compressible, non-directly compressible and moisture sensitive grades.

Applications of MCC in Pharmaceuticals

Tableting: Directly compressible MCC grades serve as excellent binders and diluents in tablets due to porous structure, oil absorption capacity, proper flow and compressibility. They provide mechanical strength and control drug release from tablets.

Capsules: MCC is widely used as filler in hard and soft gelatin capsules. It improves flow properties of powders during encapsulation and acts as buffer absorbing moisture inside capsules.

Suspensions and Emulsions: MCC stabilizes suspensions and emulsions by increasing viscosity and reducing sedimentation or creaming. It modifies drug release from these dosage forms.

Sustained Release Formulations: MCC matrices prepared by wet granulation provide sustained and prolonged drug release from controlled release pellets, tablets and implants.

Other Uses: It also finds applications as disintegrant, emulsion stabilizer, stabilizing excipient in lyophilized injections, bulking agent in chewable tablets, diluent in pharmaceutical powders, binding agent in dry powders for inhalation, and thickening agent in ophthalmic solutions.

Industry Standards for MCC

Various pharmacopeial standards like British Pharmacopoeia (BP), United States Pharmacopeia (USP) and European Pharmacopeia (Ph.Eur.) specify acceptance criteria for identification tests, loss on drying, content of reducing sugars, pH, solubility index, uniformity of dosage units and microbial limits for MCC conforming to different grades. These standards help ensure consistent quality, purity and safety of MCC used in pharmaceutical manufacturing.

With continuously evolving pharmaceutical technologies requiring functional excipients, MCC is expected to play an integral role in development of new drug delivery systems. It has potential for applications in 3D printed medicines, micro and nanotechnologies for modified drug release, and cellulose based biomaterials for implants and tissue engineering. Advanced characterization techniques will facilitate better understanding of complex mechanisms behind functionality of MCC. Overall, microcrystalline cellulose will remain a leading pharmaceutical excipient to drive innovation.

This article presented an overview of microcrystalline cellulose covering its production, properties, characterization techniques and widespread applications in pharmaceutical dosage forms as per current industry standards. With unmatched versatility and functionality, MCC has established itself as a pillar in the pharmaceutical excipients industry. Its future prospects seem very promising with evolving drug delivery technologies relying more on its binding, viscosity enhancing and modified release capabilities. Thus, MCC will likely continue to be an indispensable pharmaceutical excipient globally in the years to come.

Get more insights, On Microcrystalline Cellulose